FORBES – Today, with the new risks posed by Covid, how do we provide the best care for people with non-Covid- related disease? For diagnosed cancer patients, these risks may warrant a re-evaluation of the common standards of treatment.
“Covid has had a very negative impact, as cancer screening is down by about 50%,” says Oncologist Dr. Adam Dicker, Director at the Jefferson Center for Digital Health. “Most predictions suggest that a larger number of patients will present with a more advanced stage of disease because of the decrease in screening and fear of Covid. It seems like the end result will be more patients with advanced disease and lower cure rates because their cancers were diagnosed at a much later stage.”
Learn more here about innovations in the future of precision medicine